Dr. Benjamin Lebwohl, MD

Dr. Lebwohl practices at Trustees of Columbia University in the City of New York in New York, New York.

Dr. Lebwohl's NPI, 1386680064, was assigned on June 21, 2006. Dr. Lebwohl graduated from Vagelos College of Physicians and Surgeons in 2003. Dr. Lebwohl holds New York license 233671.

Dr. Lebwohl's primary practice is Trustees of Columbia University in the City of New York, at 630 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 342-5155.

Dr. Lebwohl's primary practice is Trustees of Columbia University in the City of New York in New York, New York. Dr. Lebwohl is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Lebwohl to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lebwohl practices. Vendor and product names are available with a free account.

Gastroenterology is Dr. Lebwohl's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Lebwohl is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Lebwohl's licenses on file in 2 states: New York and New Jersey.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic inflammatory bowel disease (IBD), colonoscopy, fatty liver, gastrointestinal bleeding, gastrointestinal inflammation and hemorrhoids among the conditions Dr. Lebwohl treats.

CMS data shows 272 Medicare services from Dr. Lebwohl across 6 procedure codes in 2024, for 221 Medicare patients. Medicare paid $33,854 for them.

CMS counts 221 Medicare patients who saw Dr. Lebwohl in 2024. The largest group is 65 to 74, with 94 patients. 75% of them have high cholesterol, and 66% have high blood pressure. 14% are also on Medicaid. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lebwohl's median patient age at 58, with 55% women.

In 2024, Dr. Lebwohl wrote 365 Medicare Part D claims for 128 patients. 81% of them were for generic drugs. CMS names the drug for 244 of them, across 9 drugs with 11 or more claims each, at $28,542 in total drug cost. In 2023, CMS named 345 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Lebwohl for performance year 2024, reported through an alternative payment model (APM). Dr. Lebwohl accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lebwohl as offering telehealth. CMS counts 62 procedures of colonoscopy by Dr. Lebwohl, more than 68% of the clinicians it reports for that procedure.

Dmand AI links 430 papers to Dr. Lebwohl, published from 2008 to 2025. 2020 was the busiest year, with 37. The most frequent topics are Celiac Disease, Diet, Gluten-Free and Biopsy. Dr. Lebwohl has published most often in Dig Dis Sci. Dr. Lebwohl's most frequent co-authors are Peter H.r. Green, MD, Alfred I. Neugut, MD, PhD and Suzanne Kwoka Lewis, MD.

Dmand AI links Dr. Lebwohl to 3 clinical trials. Conditions studied include Celiac Disease and Malabsorption Syndromes.

CMS Open Payments shows 18 general payments to Dr. Lebwohl from 7 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 91% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $11,513.

Dmand AI lists 1 award for Dr. Lebwohl.

Dr. Lebwohl graduated from Vagelos College of Physicians and Surgeons in 2003.

Dr. Lebwohl is in network with 15 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.